These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27349159)

  • 1. Influence of law changes affecting synthetic cannabinoid availability and frequency of hospital presentations: 4-year national survey.
    Glue P; Courts J; Gray A; Patterson T
    N Z Med J; 2016 Apr; 129(1433):37-40. PubMed ID: 27349159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act.
    Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI
    Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of the 2013 Psychoactive Substances Act and mental health harms from synthetic cannabinoids.
    Glue P; Courts J; MacDonald M; Gale C; Mason E
    N Z Med J; 2015 May; 128(1414):15-8. PubMed ID: 26117386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical increase in synthetic cannabinoid emergency-related presentations after a citywide ban: Lessons from Houston, Texas.
    Mathai D; Gordon M; Muchmore P; Matorin A; Shah A; Moukaddam N
    Bull Menninger Clin; 2016; 80(4):357-370. PubMed ID: 27936903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.
    Tapp L; Ramsey JG; Wen A; Gerona R
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1291-1294. PubMed ID: 29190268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016.
    Springer YP; Gerona R; Scheunemann E; Shafer SL; Lin T; Banister SD; Cooper MP; Castrodale LJ; Levy M; Butler JC; McLaughlin JB
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(40):1108-1111. PubMed ID: 27736839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
    Winstock A; Lynskey M; Borschmann R; Waldron J
    J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day.
    Andrews R; Jorge R; Christie R; Gallegos A
    Drug Test Anal; 2023 Apr; 15(4):378-387. PubMed ID: 36507715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of synthetic cannabinoids: Update 2015.
    Tournebize J; Gibaja V; Kahn JP
    Subst Abus; 2017; 38(3):344-366. PubMed ID: 27715709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland.
    Wilkins C; Prasad J; Wong KC; Rychert M; Graydon-Guy T
    N Z Med J; 2016 Mar; 129(1431):51-8. PubMed ID: 27005874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalisation associated with use of the synthetic cannabinoid K2.
    Glue P; Al-Shaqsi S; Hancock D; Gale C; Strong B; Schep L
    N Z Med J; 2013 Jun; 126(1377):18-23. PubMed ID: 23831873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.
    Kikura-Hanajiri R; Kawamura NU; Goda Y
    Drug Test Anal; 2014; 6(7-8):832-9. PubMed ID: 24573957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young peoples awareness and support for tobacco control legislation: A study among in-school youth in Lagos, Nigeria.
    Odukoya OO; Chife JO; Odeyemi KA; Nwangwu GI
    Nig Q J Hosp Med; 2015; 25(3):193-201. PubMed ID: 27295813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents.
    Ninnemann AL; Jeong Choi H; Stuart GL; Temple JR
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Jan; 80(20):5042-7. PubMed ID: 25730924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal controls on cannabimimetics: an international dilemma?
    King LA
    Drug Test Anal; 2014; 6(1-2):80-7. PubMed ID: 23881527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.
    Barratt MJ; Potter GR; Wouters M; Wilkins C; Werse B; Perälä J; Pedersen MM; Nguyen H; Malm A; Lenton S; Korf D; Klein A; Heyde J; Hakkarainen P; Frank VA; Decorte T; Bouchard M; Blok T
    Int J Drug Policy; 2015 Mar; 26(3):238-49. PubMed ID: 25576247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.